AAAAAA

   
Results: 1-25 | 26-50 | 51-52
Results: 1-25/52
SCIENCE, MEDICINE, AND THE FUTURE - INFECTION WITH HIV-1
Authors: GRAHAM BS
Citation: Bs. Graham, SCIENCE, MEDICINE, AND THE FUTURE - INFECTION WITH HIV-1, BMJ. British medical journal, 317(7168), 1998, pp. 1297-1301
IMMUNOPATHOLOGY OF RESPIRATORY SYNCYTIAL VIRUS-INFECTION - USING KNOCKOUT MICE TO STUDY PATHOGENESIS
Authors: GRAHAM BS KAHWASH S DURBIN JE
Citation: Bs. Graham et al., IMMUNOPATHOLOGY OF RESPIRATORY SYNCYTIAL VIRUS-INFECTION - USING KNOCKOUT MICE TO STUDY PATHOGENESIS, Modern pathology, 11(1), 1998, pp. 2-2
A 17-YEAR-OLD WITH RASH, FEVER, MYALGIAS, AND NEPHRITIS
Authors: BYRD VM GRAHAM BS STOCK KJ FOGO A
Citation: Vm. Byrd et al., A 17-YEAR-OLD WITH RASH, FEVER, MYALGIAS, AND NEPHRITIS, American journal of kidney diseases, 32(5), 1998, pp. 848-852
PRIOR INFECTION WITH RSV PROTECTS MICE FROM AIRWAY HYPERRESPONSIVENESS CAUSED BY RSV INFECTION DURING ALLERGIC AIRWAY SENSITIZATION
Authors: PEEBLES RS SHELLER JR GRAHAM BS
Citation: Rs. Peebles et al., PRIOR INFECTION WITH RSV PROTECTS MICE FROM AIRWAY HYPERRESPONSIVENESS CAUSED BY RSV INFECTION DURING ALLERGIC AIRWAY SENSITIZATION, Journal of allergy and clinical immunology, 101(1), 1998, pp. 615-615
PRIMING WITH SECRETED GLYCOPROTEIN-G OF RESPIRATORY SYNCYTIAL VIRUS (RSV) AUGMENTS INTERLEUKIN-5 PRODUCTION AND TISSUE EOSINOPHILIA AFTER RSV CHALLENGE
Authors: JOHNSON TR JOHNSON JE ROBERTS SR WERTZ GW PARKER RA GRAHAM BS
Citation: Tr. Johnson et al., PRIMING WITH SECRETED GLYCOPROTEIN-G OF RESPIRATORY SYNCYTIAL VIRUS (RSV) AUGMENTS INTERLEUKIN-5 PRODUCTION AND TISSUE EOSINOPHILIA AFTER RSV CHALLENGE, Journal of virology, 72(4), 1998, pp. 2871-2880
IMMUNOLOGICAL AND VIROLOGICAL ANALYSES OF PERSONS INFECTED BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WHILE PARTICIPATING IN TRIALS OF RECOMBINANT GP120 SUBUNIT VACCINES
Authors: CONNOR RI KORBER BTM GRAHAM BS HAHN BH HO DD WALKER BD NEUMANN AU VERMUND SH MESTECKY J JACKSON S FENAMORE E CAO Y GAO F KALAMS S KUNSTMAN KJ MCDONALD D MCWILLIAMS N TRKOLA A MOORE JP WOLINSKY SM
Citation: Ri. Connor et al., IMMUNOLOGICAL AND VIROLOGICAL ANALYSES OF PERSONS INFECTED BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WHILE PARTICIPATING IN TRIALS OF RECOMBINANT GP120 SUBUNIT VACCINES, Journal of virology, 72(2), 1998, pp. 1552-1576
IMMUNE-RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 INDUCEDBY CANARYPOX EXPRESSING HIV-1(MN) GP120, HIV-1(SF2) RECOMBINANT GP120, OR BOTH VACCINES IN SERONEGATIVE ADULTS
Authors: CLEMENTSMANN ML WEINHOLD K MATTHEWS TJ GRAHAM BS GORSE GJ KEEFER MC MCELRATH MJ HSIEH RH MESTECKY J ZOLLAPAZNER S MASCOLA J SCHWARTZ D SILICIANO R COREY L WRIGHT PF BELSHE R DOLIN R JACKSON S XU S FAST P WALKER MC STABLEIN D EXCLER JL TARTAGLIA J DULIEGE AM SINANGIL F PAOLETTI E
Citation: Ml. Clementsmann et al., IMMUNE-RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 INDUCEDBY CANARYPOX EXPRESSING HIV-1(MN) GP120, HIV-1(SF2) RECOMBINANT GP120, OR BOTH VACCINES IN SERONEGATIVE ADULTS, The Journal of infectious diseases, 177(5), 1998, pp. 1230-1246
ANALYSIS OF INTERCURRENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTIONS IN PHASE-I AND PHASE-II TRIALS OF CANDIDATE AIDS VACCINES
Authors: GRAHAM BS MCELRATH MJ CONNOR RI SCHWARTZ DH GORSE GJ KEEFER MC MULLIGAN MJ MATTHEWS TJ WOLINSKY SM MONTEFIORI DC VERMUND SH LAMBERT JS COREY L BELSHE RB DOLIN R WRIGHT PF KORBER BT WOLFF MC FAST PE
Citation: Bs. Graham et al., ANALYSIS OF INTERCURRENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTIONS IN PHASE-I AND PHASE-II TRIALS OF CANDIDATE AIDS VACCINES, The Journal of infectious diseases, 177(2), 1998, pp. 310-319
VITAMIN-A THERAPY FOR RESPIRATORY SYNCYTIAL VIRUS-INFECTION
Authors: NEUZIL KM GRUBER WC GRAHAM BS
Citation: Km. Neuzil et al., VITAMIN-A THERAPY FOR RESPIRATORY SYNCYTIAL VIRUS-INFECTION, The Pediatric infectious disease journal, 16(1), 1997, pp. 84-85
SAFETY PROFILE OF PHASE-I AND PHASE-II PREVENTIVE HIV TYPE-1 ENVELOPEVACCINATION - EXPERIENCE OF THE NIAID AIDS VACCINE EVALUATION GROUP
Authors: KEEFER MC WOLFF M GORSE GJ GRAHAM BS COREY L CLEMENTSMANN ML VERANIKETTER N ERB S SMITH CM BELSHE RB WAGNER LJ MCELRATH MJ SCHWARTZ DH FAST P CHARRON K REYNOLDS MJ ZIMMERMAN E JONES K HARRIS M FREY SE KENNEDY DJ ISRAEL H BERRY C READ B SPITZ T PACATTE T DOLIN R REICHMAN RC LAMBERT J DEMETER L ROBERTS NJ PUGLIESE M BERGER D BURKE J SCOTT T BLACKSTONE E WRIGHT PF BRAEUNER M RYBCZYK GK CRUMBO K BATTLE W CORNELL R OWENS D JENNINGS M HARBISON MA HENSMAN BJ BARR P STABLEIN DM VOSS T PALLAS S LOMAX N KOFF W LAWRENCE D JOHNSTON M SAVARESE B WESCOTT SL
Citation: Mc. Keefer et al., SAFETY PROFILE OF PHASE-I AND PHASE-II PREVENTIVE HIV TYPE-1 ENVELOPEVACCINATION - EXPERIENCE OF THE NIAID AIDS VACCINE EVALUATION GROUP, AIDS research and human retroviruses, 13(14), 1997, pp. 1163-1177
DETERMINANTS AND KINETICS OF CYTOKINE EXPRESSION PATTERNS IN LUNGS OFVACCINATED MICE CHALLENGED WITH RESPIRATORY SYNCYTIAL VIRUS
Authors: TANG YW NEUZIL KM FISCHER JE ROBINSON FW PARKER RA GRAHAM BS
Citation: Yw. Tang et al., DETERMINANTS AND KINETICS OF CYTOKINE EXPRESSION PATTERNS IN LUNGS OFVACCINATED MICE CHALLENGED WITH RESPIRATORY SYNCYTIAL VIRUS, Vaccine, 15(6-7), 1997, pp. 597-602
ADJUVANTS INFLUENCE THE QUANTITATIVE AND QUALITATIVE IMMUNE-RESPONSE IN BALB C MICE IMMUNIZED WITH RESPIRATORY SYNCYTIAL VIRUS FG SUBUNIT VACCINE/
Authors: NEUZIL KM JOHNSON JE TANG YW PRIEELS JP SLAOUI M GAR N GRAHAM BS
Citation: Km. Neuzil et al., ADJUVANTS INFLUENCE THE QUANTITATIVE AND QUALITATIVE IMMUNE-RESPONSE IN BALB C MICE IMMUNIZED WITH RESPIRATORY SYNCYTIAL VIRUS FG SUBUNIT VACCINE/, Vaccine, 15(5), 1997, pp. 525-532
SOLITARY PAINFUL PIEZOGENIC PEDAL PAPULE
Authors: GRAHAM BS BARRETT TL
Citation: Bs. Graham et Tl. Barrett, SOLITARY PAINFUL PIEZOGENIC PEDAL PAPULE, Journal of the American Academy of Dermatology, 36(5), 1997, pp. 780-781
OVEREXPRESSION OF INTERLEUKIN-4 DELAYS VIRUS CLEARANCE IN MICE INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS
Authors: FISCHER JE JOHNSON JE KULIZADE RK JOHNSON TR AUNG S PARKER RA GRAHAM BS
Citation: Je. Fischer et al., OVEREXPRESSION OF INTERLEUKIN-4 DELAYS VIRUS CLEARANCE IN MICE INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS, Journal of virology, 71(11), 1997, pp. 8672-8677
T-CELL SOURCE OF TYPE-1 CYTOKINES DETERMINES ILLNESS PATTERNS IN RESPIRATORY SYNCYTIAL VIRUS-INFECTED MICE
Authors: TANG YW GRAHAM BS
Citation: Yw. Tang et Bs. Graham, T-CELL SOURCE OF TYPE-1 CYTOKINES DETERMINES ILLNESS PATTERNS IN RESPIRATORY SYNCYTIAL VIRUS-INFECTED MICE, The Journal of clinical investigation, 99(9), 1997, pp. 2183-2191
POTENTIAL FOR DIRECTING APPROPRIATE RESPONSES TO VACCINES BY CYTOKINEMANIPULATION
Authors: TANG YW GRAHAM BS
Citation: Yw. Tang et Bs. Graham, POTENTIAL FOR DIRECTING APPROPRIATE RESPONSES TO VACCINES BY CYTOKINEMANIPULATION, CLINICAL IMMUNOTHERAPEUTICS, 5(5), 1996, pp. 327-333
CYTOKINE RELEASE AND INNATE IMMUNITY IN RESPIRATORY VIRAL-INFECTION
Authors: NEUZIL KM GRAHAM BS
Citation: Km. Neuzil et Bs. Graham, CYTOKINE RELEASE AND INNATE IMMUNITY IN RESPIRATORY VIRAL-INFECTION, Seminars in virology, 7(4), 1996, pp. 255-264
SAFETY AND IMMUNOGENICITY OF ENV-2-3, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CANDIDATE VACCINE, IN COMBINATION WITH A NOVEL ADJUVANT, MTP-PEMF59/
Authors: KEEFER MC GRAHAM BS MCELRATH MJ MATTHEWS TJ STABLEIN DM COREY L WRIGHT PF LAWRENCE D FAST PE WEINHOLD K HSIEH RH CHERNOFF D DEKKER C DOLIN R
Citation: Mc. Keefer et al., SAFETY AND IMMUNOGENICITY OF ENV-2-3, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CANDIDATE VACCINE, IN COMBINATION WITH A NOVEL ADJUVANT, MTP-PEMF59/, AIDS research and human retroviruses, 12(8), 1996, pp. 683-693
RESPIRATORY SYNCYTIAL VIRUS-INFECTION ENHANCES THE RESPONSE TO LARYNGEAL CHEMOSTIMULATION AND INHIBITS AROUSAL FROM SLEEP IN YOUNG LAMBS
Authors: LINDGREN C LIN J GRAHAM BS GRAY ME PARKER RA SUNDELL HW
Citation: C. Lindgren et al., RESPIRATORY SYNCYTIAL VIRUS-INFECTION ENHANCES THE RESPONSE TO LARYNGEAL CHEMOSTIMULATION AND INHIBITS AROUSAL FROM SLEEP IN YOUNG LAMBS, Acta paediatrica, 85(7), 1996, pp. 789-797
IMMUNIZATION WITH ENVELOPE SUBUNIT VACCINE PRODUCTS ELICITS NEUTRALIZING ANTIBODIES AGAINST LABORATORY-ADAPTED BUT NOT PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: MASCOLA JR SNYDER SW WEISLOW OS BELAY SM BELSHE RB SCHWARTZ DH CLEMENTS ML DOLIN R GRAHAM BS GORSE GJ KEEFER MC MCELRATH MJ WALKER MC WAGNER KF MCNEIL JG MCCUTCHAN FE BURKE DS
Citation: Jr. Mascola et al., IMMUNIZATION WITH ENVELOPE SUBUNIT VACCINE PRODUCTS ELICITS NEUTRALIZING ANTIBODIES AGAINST LABORATORY-ADAPTED BUT NOT PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, The Journal of infectious diseases, 173(2), 1996, pp. 340-348
SAFETY AND IMMUNOGENICITY OF A CANDIDATE HIV-1 VACCINE IN HEALTHY-ADULTS - RECOMBINANT GLYCOPROTEIN (RGP)-120 - A RANDOMIZED, DOUBLE-BLIND TRIAL
Authors: GRAHAM BS KEEFER MC MCELRATH MJ GORSE GJ SCHWARTZ DH WEINHOLD K MATTHEWS TJ ESTERLITZ JR SINANGIL F FAST PE WRIGHT PF DOLIN R COREY L BELSHE RB CLEMENTS ML BOLOGNESI DP STABLEIN DM CHERNOFF D DULIEGE AM WALKER CM
Citation: Bs. Graham et al., SAFETY AND IMMUNOGENICITY OF A CANDIDATE HIV-1 VACCINE IN HEALTHY-ADULTS - RECOMBINANT GLYCOPROTEIN (RGP)-120 - A RANDOMIZED, DOUBLE-BLIND TRIAL, Annals of internal medicine, 125(4), 1996, pp. 270
PROTECTIVE ROLE OF TNF-ALPHA IN RESPIRATORY SYNCYTIAL VIRUS-INFECTIONIN-VITRO AND IN-VIVO
Authors: NEUZIL KM TANG YW GRAHAM BS
Citation: Km. Neuzil et al., PROTECTIVE ROLE OF TNF-ALPHA IN RESPIRATORY SYNCYTIAL VIRUS-INFECTIONIN-VITRO AND IN-VIVO, The American journal of the medical sciences, 311(5), 1996, pp. 201-204
PATHOGENESIS OF RESPIRATORY SYNCYTIAL VIRUS VACCINE-AUGMENTED PATHOLOGY
Authors: GRAHAM BS
Citation: Bs. Graham, PATHOGENESIS OF RESPIRATORY SYNCYTIAL VIRUS VACCINE-AUGMENTED PATHOLOGY, American journal of respiratory and critical care medicine, 152(4), 1995, pp. 63-66
PHASE-I PHASE-II PREVENTIVE VACCINE TRIALS - CONFERENCE SUMMARY
Authors: WALKER MC FAST PE GRAHAM BS BELSHE R DOLIN R
Citation: Mc. Walker et al., PHASE-I PHASE-II PREVENTIVE VACCINE TRIALS - CONFERENCE SUMMARY, AIDS research and human retroviruses, 11(10), 1995, pp. 1279-1285
INTERFACE BETWEEN ANIMAL-MODELS AND CLINICAL-PHASE-I TRIALS WORKSHOP - CONFERENCE SUMMARY
Authors: GRAHAM BS SAWYER LA WALKER MC FAST PE HU SL
Citation: Bs. Graham et al., INTERFACE BETWEEN ANIMAL-MODELS AND CLINICAL-PHASE-I TRIALS WORKSHOP - CONFERENCE SUMMARY, AIDS research and human retroviruses, 11(10), 1995, pp. 1305-1306
Risultati: 1-25 | 26-50 | 51-52